EarningsQ3 2025 Earnings Report

Santen Pharmaceutical Co (4536N) Q3 2025 Earnings Report

0 Followers

MX:4536N Q3 2025 EPS Results

Actual EPS$2.84

Consensus EPS$3.41

Beat/MissMissed by -$0.57

One Year Ago EPS$2.95

Actual Revenue$8.48B

Expected Revenue$8.80B

Beat/MissMissed by -$325.44M

YoY Revenue Growth-4.56%

QuarterQ3 2025

Date02/05/2026

TimeTBA

Conference CallThursday, February 5, 2026

MX:4536N Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q2)	3.24 / -	2.843	―
Aug 06, 2026	2026 (Q1)	2.47 / 2.60	2.015	29.21% (+0.59)
May 12, 2026	2025 (Q4)	3.58 / 5.57	2.998	85.80% (+2.57)
Feb 05, 2026	2025 (Q3)	3.41 / 2.84	2.947	-3.67% (-0.11)
Nov 06, 2025	2025 (Q2)	2.43 / 2.84	2.709	4.94% (+0.13)
Aug 07, 2025	2025 (Q1)	2.78 / 2.01	3.442	-41.47% (-1.43)
May 13, 2025	2024 (Q4)	2.01 / 3.00	1.906	57.30% (+1.09)
Feb 06, 2025	2024 (Q3)	3.04 / 2.95	2.35	25.40% (+0.60)
Nov 07, 2024	2024 (Q2)	2.52 / 2.71	2.807	-3.48% (-0.10)
Aug 06, 2024	2024 (Q1)	3.02 / 3.44	3.249	5.94% (+0.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed